Turtle Cameron
Related Filers (3)
- BridgeBio Pharma, Inc. (16)
- Eidos Therapeutics, Inc. (15)
- Spyre Therapeutics, Inc. (3)
- Show More ...
Ownership (34)
4
Friday, 2/2/2024
Spyre Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/27/2023
Spyre Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 6/30/2023
Aeglea BioTherapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 1/28/2021
Eidos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/29/2020
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/16/2020
Eidos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/25/2020
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/13/2020
Eidos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/9/2020
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/3/2020
Eidos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 10/2/2020
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/22/2020
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/16/2020
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/15/2020
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/11/2020
Eidos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/2/2020
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/5/2020
Eidos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/2/2020
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/5/2020
Eidos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/28/2020
Eidos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/21/2020
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/5/2020
Eidos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/29/2020
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 4/10/2020
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/13/2020
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/5/2020
Eidos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/10/2020
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/10/2019
Eidos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/22/2019
Eidos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/6/2019
Eidos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/3/2019
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 6/27/2019
BridgeBio Pharma, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 6/6/2019
Eidos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 11/7/2018
Eidos Therapeutics, Inc.: Initial statement of beneficial ownership of securities